FIELD: medicine.
SUBSTANCE: invention relates to a method for the treatment of inflammatory bowel disease in a pediatric patient. The method provides intravenous administration to a pediatric patient weighing less than 30 kg with inflammatory bowel disease (IBD) of the first dose of 200 mg vedolizumab, the second dose of 200 mg two weeks after the first dose and the third dose of 200 mg six weeks after the first dose. Administration of a fixed dose of 200 mg to a pediatric patient less than 30 kg is safe.
EFFECT: invention makes it possible to increase the effectiveness of the treatment of a pediatric patient weighing less than 30 kg, which does not lead to the development of the observed undesirable effects, and to prevent the possibility of miscalculations when calculating the dose based on weight.
11 cl, 2 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING CHRONIC POUCH ILEITIS | 2018 |
|
RU2822135C2 |
| DOSES AND ADMINISTRATION OF ANTIBODIES AGAINST C5 FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) | 2020 |
|
RU2822664C2 |
| ANTIBODIES, THEIR APPLICATION AND METHODS OF APPLICATION | 2016 |
|
RU2725221C2 |
| A NEW COMBINATION FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASMS | 2016 |
|
RU2742494C2 |
| ANTI-αvβ8 ANTIBODIES AND COMPOSITIONS AND THEIR USE | 2019 |
|
RU2812478C2 |
| PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY | 2008 |
|
RU2523894C2 |
| METHODS OF TREATING CANCER USING ANTI-PD-1 ANTIBODIES AND ANTI-CTLA4 ANTIBODIES | 2019 |
|
RU2825835C2 |
| METHOD FOR TREATING MULTIPLE SCLEROSIS | 2015 |
|
RU2757961C2 |
| GM-CSF-NEUTRALIZING ANTIBODIES FOR USE IN TREATING RHEUMATOID ARTHRITIS OR AS ANALGESICS | 2014 |
|
RU2714919C2 |
| IL-18-BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES | 2016 |
|
RU2755691C2 |
